Suzanne Ghiloni, RN, BSN, CDE Suzanne Ghiloni is a Certified Diabetes Educator working at the Joslin Diabetes Center in Boston for 26 years. She provides direct clinical care in individual and group settings for patients with type 1, type 2, and gestational diabetes. The majority of her practice involves intensive insulin therapy and insulin pump therapy. A subspecialty is her involvement as lead nurse educator at the Diabetes and Pregnancy Program, an affiliation of the Joslin Diabetes Center and Beth Israel Deaconess Medical Center. She is co-author of several articles in Diabetes Technology & Therapeutics and Diabetes Forecast. Other written work includes chapter authorship for the textbook Diabetes Complicating Pregnancy: The Joslin Clinic Method and an upcoming Joslin publication, Staying Healthy with Diabetes: Pregnancy. Research activities include participation in the JDRF Artificial Pancreas Project (2007–20008) and The Seven Center Study – Use of the Paradigm 722 System to Improve Glycemic Control in Adult and Adolescent Subjects with Type 1 Diabetes: A Multi-Center, Randomized Controlled Trial (2005–2007). Irl B. Hirsch, MD Dr. Hirsch is a professor of medicine and holds the Diabetes Treatment and Teaching Chair at the University of Washington School of Medicine; he also is the medical director of the Diabetes Care Center at the University of Washington Medical Center in Seattle. He graduated from the University of Missouri in Columbia, Missouri, before completing his internal medicine training at the University of Miami and Mt. Sinai Medical Center in Miami, Florida. He completed his endocrinology and metabolism training at Washington University in St. Louis. Dr. Hirsch has been interested in new technologies for the treatment of diabetes, particularly those involved in the use of insulin therapy. He has also been interested in the mechanisms of how insulin comodulates inflammation with glucose and how this results in improvements in outcomes of hospitalized patients. The management of hyperglycemia in the hospital has been an interest of Dr. Hirsch’s for over 20 years, and he has been involved in national policy implementation for this issue. He is involved in numerous clinical research trials, and is currently a leader in the area of real-time continuous glucose monitoring. He also is interested in the use of computers in diabetes data management and how pattern recognition can be used to improve diabetes control, in addition to how glycemic variability noted on glucose meter downloads may be an independent risk for microvascular complications. Dr. Hirsch is an active member of the ADA, AACE, the American College of Physicians, and the American Board of Internal Medicine. He has a very active clinical practice in which 80% of patients have type 1 diabetes. He has written over 100 papers including a review of insulin in the New England Journal of Medicine, 40 editorials, numerous book chapters, and four books for patients and physicians. He is the past editor-in-chief of DOC News and Clinical Diabetes. In 2001 he was awarded Young Physician of the Year by the University of Missouri, in 2004 he was awarded the Physician Clinician of the Year award by the American Diabetes Association, and in 2006 he received the Distinguished Endocrinologist Award from the American Association of Clinical Endocrinologists. Dr. Hirsch has held numerous national ADA positions over the years including Scientific Sessions Program Committee, Scientific Sessions Chair, Board of Directors, member and later chair of the professional practice committee, and chair of several education initiatives. Locally he has served on the affiliate board and the leadership board. Howard Wolpert, MD Dr. Wolpert is Senior Physician in the Section of Adult Diabetes and Director of the Insulin Pump & Continuous Glucose Monitoring Programs at the Joslin Diabetes Center. Dr. Wolpert was raised and attended medical school in South Africa. He received residency training in Internal Medicine at Deaconess Hospital/Harvard Medical School, followed by fellowship at Brigham & Women’s Hospital and Joslin Diabetes Center, passing the Endocrinology Board examinations at the 99th percentile. His research and clinical interests focus on the implementation of intensive diabetes management and enhancing patient adherence. Dr. Wolpert is author of Smart Pumping, published by the American Diabetes Association. He is also co-author of Transitions in Care, a guidebook focusing on the issues and challenges faced by young adults during the transition to independent diabetes self-care, recently published by the American Diabetes Association. Dr. Wolpert was a principal investigator in the Star 1 trial, the first long-term randomized controlled trial evaluating the use of real-time continuous glucose monitoring (CGM) in the management of type 1 diabetes, and the recently completed JDRF-sponsored CGM trial. Over the past year he has established a structured education pathway, including a one-day program called Sensor Logic, to train adult patients at Joslin in the use of continuous glucose monitoring.